Literature DB >> 18471047

Melanoma-induced brain metastases.

Robert R McWilliams1, Ravi D Rao, Jan C Buckner, Michael J Link, Svetomir Markovic, Paul D Brown.   

Abstract

Brain metastases are a common site of metastasis from malignant melanoma, and are associated with a poor prognosis. Diagnosis of brain metastasis may also have significant implications for quality of life, and management can be difficult due to rapid progression of disease and resistance to conventional therapies. In this article, we will review the published evidence for treatment modalities for melanoma-induced brain metastases and outline future directions for research. In brief, surgical management of solitary or acutely symptomatic lesions appears to alleviate symptoms and provide the possibility of local control of disease. Stereotactic radiosurgery is an increasingly utilized technique for patients with a limited number of metastases, and presents a less invasive alternative to craniotomy. External-beam radiation alone appears effective in palliating symptoms. Chemotherapy alone is relatively ineffective, though combined chemotherapy with external-beam radiation is being investigated. Future directions include combined-modality therapy, the incorporation of novel agents, and careful consideration of the structure of clinical trials for this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471047     DOI: 10.1586/14737140.8.5.743

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  7 in total

Review 1.  Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer.

Authors:  Colin R Lindsay; Pavlina Spiliopoulou; Ashita Waterston
Journal:  Ther Adv Med Oncol       Date:  2015-03       Impact factor: 8.168

Review 2.  Brain metastases as preventive and therapeutic targets.

Authors:  Patricia S Steeg; Kevin A Camphausen; Quentin R Smith
Journal:  Nat Rev Cancer       Date:  2011-04-07       Impact factor: 60.716

3.  Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.

Authors:  Irina Mirkina; Emir Hadzijusufovic; Clemens Krepler; Mario Mikula; Diana Mechtcheriakova; Sabine Strommer; Alexander Stella; Erika Jensen-Jarolim; Christoph Höller; Volker Wacheck; Hubert Pehamberger; Peter Valent
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

4.  Characterization of the immune microenvironment in brain metastases from different solid tumors.

Authors:  Jinling Jiang; Lihong Wu; Fei Yuan; Jun Ji; Xiaojing Lin; Wanning Yang; Junwei Wu; Min Shi; Hui Yang; Yanna Ma; Xue Song; Zhenggang Zhu; Henghui Zhang; Jun Zhang
Journal:  Cancer Med       Date:  2020-02-04       Impact factor: 4.452

5.  Anaplastic pleomorphic xanthoastrocytoma with epithelioid morphology misdiagnosed and treated as melanoma.

Authors:  Mario M Dorostkar; Dinah Konnerth; Maximilian Niyazi; Niklas Thon; Max Schlaak; Kinan Hayani; Anne Guertler
Journal:  Neurooncol Adv       Date:  2022-01-25

6.  Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.

Authors:  Trude G Simonsen; Jon-Vidar Gaustad; Einar K Rofstad
Journal:  J Exp Clin Cancer Res       Date:  2015-12-15

7.  Intracranial Tumor Cell Migration and the Development of Multiple Brain Metastases in Malignant Melanoma.

Authors:  Trude G Simonsen; Jon-Vidar Gaustad; Einar K Rofstad
Journal:  Transl Oncol       Date:  2016-05-17       Impact factor: 4.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.